- Mount Sinai Begins Recruitment for Landmark Study of Adolescent Brain Development — September 13, 20106
- Defect In Process That Controls Gene Expression May Contribute To Huntington’s Disease And Other Neurodegenerative Disorders - August 15, 2016
- Specialized Nerve Cells in Brain Region Responsible for Emotional Memory Play Important Role in Fear Learning - July 14, 2016
- Motivation to Bully is Regulated by Brain Reward Circuits - June 29, 2016
- Study Suggests Depression is Driven by Networks of Genes That Span Brain Circuits — May 12, 2016
- Enzyme Dnmt1 in Developmental Myelination Process Could Lead to Better Understanding of Neurological Disorders — April 14, 2016
- Mount Sinai Chosen for 2017-2019 Edmond J. Safra Fellowship in Movement Disorders — March 28, 2016
- Mount Sinai Participates in Landmark Study to Investigate Substance Use and Adolescent Brain Development - November 2, 2015
- Joseph D Buxbaum PhD Elected to National Academy of Medicine - October 19, 2015
- Suppression of Epigenetic Brain Proteins Induces Autism-Like Syndrome - October 8, 2015
- Mount Sinai Study Finds Emotional Behavior Altered After Multiple Exposures to Anesthesia During Infancy - September 3, 2015
- Antidepressants Fine-tune Brain Reward Pathway to Lessen Neuropathic Pain - August 24, 2015
- Mount Sinai Alzheimers Disease Expert Receives Lifetime Achievement Award - August 5, 2015
- Eric J. Nestler, MD, PhD, to Lead Society for Neuroscience - July 23, 2015
- Mount Sinai Researchers Identify Genetic Markers Linking Risk for Both Type 2 Diabetes and Alzheimer’s Disease - July 16, 2015
- Human Brain May Contain a Map for Social Navigation - July 1, 2015
Study reveals how the hippocampus contributes to social behavior
- New Compounds Protect Nervous System From the Structural Damage Characteristic of Multiple Sclerosis - February 27, 2015
Pharmacological Agents Hold Promise for Several Neurodegenerative Disorders
- $2.5 Million NIH Grant to Fund Mount Sinai Research into Reducing Heroin Injection and HIV Infection - February 23, 2015
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has awarded Don C. Des Jarlais, PhD, a 2015 Avant-Garde Award.
- Mount Sinai Health System Names Director of Newly Established Ronald M. Loeb Center for Alzheimer’s Disease - February 19, 2015
Renowned neuropsychiatric researcher Alison Goate, PhD, has joined the Mount Sinai Health System as the founding Director of the Ronald M. Loeb Center for Alzheimer’s Disease.
- Growth Hormone Treatment Improves Social Impairments in Patients with Genetic Disorder Known to Cause Autism - February 18, 2015
A growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome.
- Cocaine Users Have Impaired Ability to Predict Loss - February 4, 2015
- Gift to Mount Sinai Health System Establishes Ronald M. Loeb Center for Alzheimer’s Disease - December 16, 2014
$15 Million Gift By Daniel and Margaret Loeb in Memory of Ronald M. Loeb; Center Dedicated to Alzheimer’s Disease Research
- The Mount Sinai Health System Names New Vice Chair of Neurosurgery and Director of the Cerebrovascular Surgery Program - December 4, 2014
- Behavioral Flexibility Impaired After Exposure to Oxycodone - November 17, 2014
Study reveals new mechanisms related to addiction
- Brain Protein Influences How the Brain Manages Stress; Suggests New Model of Depression - November 12, 2014
Discovery of new molecular and behavioural connections may provide a foundation for the development of new treatments to combat some forms of depression
- Changes in a Single Gene’s Action Can Control Addiction- and Depression-Related Behaviors - November 10, 2014
New DNA regulatory technique modifies the environment around a single gene to control gene expression and behavioral consequences
- Changes in Scores of Genes Contribute to Autism Risk - October 29, 2014
Newfound Genetic Differences Provide Many Hints at Causes
- Stress-Related Inflammation May Increase Risk for Depression - October 20, 2014
- Mount Sinai a Lead Site in NIH-Funded Rare Diseases Consortium Studying Autism and Intellectual Disability - October 15, 2014
10-institution study seeks to pilot new treatment approaches
- Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain - September 16, 2014
Detection while patient is still alive improves accuracy of diagnosis and enables estimation of prevalence and risk
- New Study Examines Impact of Violent Media on the Brain - September 10, 2014
Exposure to violence has a different effect on people with aggressive traits
- Common Gene Variants Account for Most of the Genetic Risk for Autism - July 21, 2014
Heritability trumps spontaneous glitches, environment
- Cocoa Extract May Counter Specific Mechanisms of Alzheimer’s Disease - June 23, 2014
Insights into mechanisms behind cocoa’s benefit may lead to new treatments or dietary regimens
- Lawrence C. Newman, MD, of Mount Sinai Roosevelt Elected New President of The American Headache Society - June 4, 2014
Neurologist is Also Director of The Headache Institute at Mount Sinai Roosevelt
- Icahn School of Medicine at Mount Sinai Joins Autism BrainNet Tissue Bank - May 29, 2014
Consortium of premiere research institutions will provide critically needed brain tissue for autism research
- Mount Sinai Researchers Lead International Advisory Committee To Define The Clinical Course of Multiple Sclerosis - May 28, 2014
Re-examination of standardized multiple sclerosis descriptions published in 1996 to influence future research studies and clinical practice
- Mount Sinai Researchers Identify Subtle Changes that May Occur in Neural Circuits Due to Cocaine Addiction - May 7, 2014
Research May Offer a Unique Pathway for Targeting New Therapeutics for Addiction Treatment
- Genetic and Environmental Influences Are Equally Important Risk Factors for Autism Spectrum Disorder - May 5, 2014
- Mount Sinai Researchers Identify Genetic Alterations in Shared Biological Pathways as Major Risk Factor for Autism Spectrum Disorder - April 24, 2014
A substantial proportion of risk for developing autism spectrum disorders (ASD), resides in genes that are part of specific, interconnected biological pathways, according to researchers from the Icahn School of Medicine at Mount Sinai.
- Intravenously Administered Ketamine Shown to Reduce Symptoms of Chronic Post-Traumatic Stress Disorder - April 16, 2014
Researchers from Mount Sinai demonstrate proof of concept for new, rapidly-acting pharmacotherapy for treatment of PTSD.
- Intranasal Ketamine Confers Rapid Antidepressant Effect in Depression - April 8, 2014
Mount Sinai team cautiously optimistic that door could swing open to a new antidepressant drug class.
- Susan B. Bressman, MD, Honored as "National Physician of the Year" By Castle Connolly Medical, Ltd., Publisher of the Annual America's Top Doctors® Guides - April 1, 2014
Dr. Bressman was recognized at the Ninth Annual Castle Connolly Medical Ltd. National Physician of the Year Awards on March 31.
- Avoiding Harmful Byproducts of Heat-Processed Foods Protects Against Risk of Alzheimer’s Disease and Diabetes - February 24, 2014
Modifying dietary intake of Advanced Glycation Endproducts, or AGEs, bolsters body’s defenses against Alzheimer’s and Metabolic Syndrome.
- Opioid Abuse Initiates Specific Protein Interactions in Neurons in Brain’s Reward System - February 24, 2014
RGS9-2 protein affects not only addiction, but analgesic relief and tolerance.
- With Large-Scale New Studies, Mount Sinai Scientists Help Underscore the Genetic Complexity in Schizophrenia - January 22, 2014
Largest exome studies of schizophrenia to date establish critical new scientific resources for biomedical community and the possibility of more tailored treatment for patients.
- Novel Nanotherapy Breakthrough May Help Reduce Recurrent Heart Attacks and Stroke - January 20, 2014
Icahn School of Medicine at Mount Sinai designs HDL nanoparticle to deliver statin medication inside inflamed blood vessels to prevent repeat heart attacks and stroke.
- Icahn School of Medicine at Mount Sinai Named to New NIH Stroke Research Network - December 20, 2013
Research collaborative network aims to expedite stroke clinical trials, build greater expertise in stroke.
- Four Researchers from Icahn School of Medicine at Mount Sinai Among the 400 Most Highly Influential Biomedical Researchers in the World - November 25, 2013
Powerful researchers include Dr. Dennis S. Charney, Dr. Carlos Cordon-Cardo, Dr. Valentin Fuster, and Dr. Eric J. Nestler.
- Mount Sinai Researchers Identify Molecular Changes in the Brain that May Increase Risk for Multiple Sclerosis - November 25, 2013
First genome-wide study in brain tissue from MS patients.
- Society for Neuroscience Honors Rita Z. Goldstein, PhD, with the Jacob P. Waletzky Award - November 1, 2013
Mount Sinai Researcher Honored for Translational Addiction Research
- Two Mount Sinai Physicians Elected to the Institute of Medicine - October 24, 2013
Diane E. Meier, MD and Pamela Sklar, MD, PhD, recognized for Outstanding Professional Achievement and Commitment to Service.
- Perception of marijuana as a "safe drug" is scientifically inaccurate - August 27, 2013
The nature of the teenage brain makes users of cannabis particularly at risk of developing addictive behaviors.
- Mount Sinai Researchers Publish New Edition of Psychiatry "Bible" - August 7, 2013
In light of the accelerated pace of discovery in understanding psychiatric illnesses, experts from Mount Sinai have published the 4th edition of Neurobiology of Mental Illness.
- ADHD Drug Shows Promise in Treating Addiction - June 26, 2013
A single dose of a commonly-prescribed attention deficit hyperactivity disorder drug helps improve brain function in cocaine addiction.
- Brain Development in Chimpanzees Provides Insight into the Evolution of the Human Brain - June 13, 2013
The development of brain regions crucial to learning occurred before apes evolved into humans.
- Mount Sinai Researchers Provide the First Comprehensive and Prospective Characterization of a Genetic Subtype of Autism - June 11, 2013
First study to describe clinical presentation of Phelan-McDermid Syndrome will help guide future research and clinical care
- Pioneering Study Demonstrates Benefit of Imaging Technique in Identifying Mental Illness - June 5, 2013
MRI may be an effective way to diagnose mental illnesses such as bipolar disorder, according to experts from the Icahn School of Medicine at Mount Sinai.
- Mount Sinai Researchers Identify New Drug Target for Depression and Neuropathic Pain - April 29, 2013
Increased levels of brain protein in response to antidepressants may lead to new therapies
- Mount Sinai Researchers Identify Promising Drug Target for Depression - February 17, 2013
Decreased expression of a protein called Rac1 may be a primary cause of depression, according to a new study in human and mouse brains.
- Facts about How Mount Sinai is Researching and Treating Brain Diseases - December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases.
- Short DNA Strands in the Genome May be Key to Understanding Human Cognition and Diseases - November 20, 2012
Previously discarded, human-specific “junk” DNA represents untapped resource in the study of diseases like Alzheimer’s and autism
- Changes in Nerve Cells Caused by Social Isolation May Contribute to the Development of Mental Illness - November 11, 2012
Reduced production of myelin, a type of nerve fiber that is lost in diseases like MS, may also play a role in the development of mental illness.
- Mount Sinai Researchers Unveil New Targets for Depression at Neuroscience 2012 - October 15, 2012
Scientists presented important discoveries on the involvement of the immune system and dopamine on the onset of depression.
- Mount Sinai Researchers Find Brain Mechanism Behind Opioid Addiction - October 5, 2012
Chronic morphine exposure has the opposite effect on the brain compared to cocaine in mice, providing new insight into the basis of opiate addiction
- Mount Sinai Researcher Receives Prestigious National Institutes of Health Award - September 13, 2012
Anne Schaefer, MD, PhD, Assistant Professor of Neuroscience and Psychiatry, has been recognized with the Director's New Innovator Award.
- Researchers Identify Area Of The Brain That Processes Empathy - September 1, 2012
An international team led by Mount Sinai School of Medicine has shown that one area of the brain is the only activity center of empathy.
- Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice - August 8, 2012
Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease
- Wayne Goodman, MD, Receives Career Achievement Award from International OCD Foundation - July 28, 2012
The honor was presented to Dr. Goodman at the 19th Annual International OCD Foundation Conference in Chicago.
- Mount Sinai Performs First Imaging Test to Detect Alzheimer's Disease in the Clinical Setting - June 20, 2012
The new technique is expected to play a critical role in Alzheimer's disease diagnosis and in research leading to a cure.
- Mount Sinai Researcher Receives Career-Starter Research Grant for 2012-2013 - June 20, 2012
Hirofumi Morishita, MD, PhD, receives a Career-Starter Research Grant for 2012-2013 from the Knights Templar Eye Foundation.
- Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s - July 18, 2011
Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease.
- A Natural Chemical Found in Grape Seeds May Prevent Development or Progression of Alzheimer’s - July 15, 2011
Mount Sinai researchers found that polyphenols, a natural extract found in grapes, may help prevent or treat Alzheimer’s disease.
- Mount Sinai Celebrates the “Topping Off” of the New Center for Science and Medicine Building - February 7, 2011
Set to open in 2012, CSM will bring nearly a half-million square-feet of new, state-of-the-art medical research and clinical facilities to Mount Sinai.
- Mount Sinai Researchers Find That Little-Studied Gene May Boost Long-Term Memory and Enhance Cognition - January 26, 2011
Treatment with a gene called IGF-II significantly improved long-term memory. When the gene was blocked, long-term memories could not form.
- Mount Sinai Researchers Make Groundbreaking Discovery on Origin of Brain’s Immune Cells - October 21, 2010
New study could lead to new treatments for degenerative brain diseases, such as Alzheimer’s, and autoimmune disorders, such as multiple sclerosis.
- Mount Sinai Researcher Awarded Renowned Institute of Medicine Prize for Outstanding Achievements in Improving Mental Health - October 11, 2010
Dr. Eric Nestler honored for his work and achievements in addiction science.
- Antihypertensive Drugs May Protect against Alzheimer’s Disease and Promote Healthy Memory - June 24, 2010
Researchers at Mount Sinai School of Medicine have found that a blood pressure drug may lessen the impact of Alzheimer’s disease and promote healthy memory.
- New Autism Susceptibility Genes Identified; Autism Genome Project Phase 2 Results Published in Nature - June 9, 2010
In collaboration with the Autism Genome Project, Mount Sinai has published phase 2 data on gene variants that may lead to new autism treatments.
- Mount Sinai Researchers Identify First Drug to Demonstrate Effect in an Animal Model of a Type of Autism - May 20, 2010
Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of an autism subtype.
- Wayne K. Goodman, MD, Honored with Mysell Lecture By Harvard Medical School - March 24, 2010
Wayne K. Goodman, MD, Chair of the Department of Psychiatry at Mount Sinai, has been selected to deliver the prestigious Mysell Lecture at Harvard.
- New Mount Sinai Support Groups Will Address the Needs of Parkinson's and Dystonia Patients and Their Caregivers - January 5, 2010
Mount Sinai launches four new support groups to assist patients with Parkinson's disease and dystonia. Topics of discussion will include nutrition, new therapies, and caregiver needs.
- Mount Sinai Researcher Led Study to Determine If Drug Slows Progression of Parkinson's Disease - September 24, 2009
C. Warren Olanow, MD, Professor and Chairman Emeritus, Department of Neurology, led an 18-month study on whether a drug used to treat Parkinson's actually slows disease progression.
- Mount Sinai Research Identifies Brain Mechanisms Associated with Borderline Personality Disorder - September 3, 2009
Through real-time imaging, researchers have collected evidence to suggest that neurological networks that help regulate emotion do not activate in patients with borderline personality disorder.
- Mount Sinai Finds Differences in Brain Scans of Patients with Borderline Personality Disorder - March 5, 2009
New research conducted by Mount Sinai physicians suggests that the brain activity of people with borderline personality disorder is different from that of people without the disorder.
- New Psychiatric Program at The Mount Sinai Medical Center Addresses Special Needs of Multiple Sclerosis Patients - February 26, 2009
The new program provides for an on-site psychiatrist to assist in the identification and management of psychiatric and psychological disorders in patients with MS, including depression.
- Gene Mutations Identified As Cause of Primary Torsion Dystonia - February 3, 2009
Mount Sinai researchers have identified mutations in gene THAP1 as a cause of primary torsion dystonia. The discovery may lead to new treatments for this debilitating disease.